Showing results (411-420 of 601) with videos related to
Sort By:
Pageof 61
Journal of Virology|August 21, 2009
Impaired plasmacytoid dendritic cell (PDC)-NK cell activity in viremic human immunodeficiency virus infection attributable to impairments in both PDC and NK cell functionSara J Conry, Kimberly A Milkovich, Nicole L Yonkers, et al.The Journal of Infectious Diseases|September 18, 1997
The effect of tenidap on cytokines, acute-phase proteins, and virus load in human immunodeficiency virus (HIV)-infected patients: correlation between plasma HIV-1 RNA and proinflammatory cytokine levelsB J Dezube, M M Lederman, B Chapman, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|October 26, 1999
HIV-1-specific cytolytic T-lymphocyte activity correlates with lower viral load, higher CD4 count, and CD8+CD38-DR- phenotype: comparison of statistical methods for measurementN M Lubaki, M E Shepherd, R S Brookmeyer, et al.The Journal of Infectious Diseases|June 29, 2002
Cryptosporidiosis stimulates an inflammatory intestinal response in malnourished Haitian childrenBeth D Kirkpatrick, Michelle M Daniels, Simone Sonia Jean, et al.Clinical and Diagnostic Laboratory Immunology|September 6, 2000
Shipment impairs lymphocyte proliferative responses to microbial antigensR A Betensky, E Connick, J Devers, et al.Antiviral Therapy|August 9, 2001
Antiretroviral activity and safety of abacavir in combination with selected HIV-1 protease inhibitors in therapy-naive HIV-1-infected adultsD McMahon, M Lederman, D W Haas, et al.Nature Communications|January 24, 2023
Polyamine metabolism impacts T cell dysfunction in the oral mucosa of people living with HIVS S Mahalingam, S Jayaraman, N Bhaskaran, et al.Journal of Thrombosis and Haemostasis : JTH|December 20, 2016
Safety and efficacy of BAY 94-9027, a prolonged-half-life factor VIIIM T Reding, H J Ng, L H Poulsen, et al.Pediatrics|November 4, 2000
Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study GroupK L O'Brien, A J Swift, J A Winkelstein, et al.The Journal of Infectious Diseases|July 29, 2010
AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core proteinRobert T Schooley, John Spritzler, Hongying Wang, et al.Pageof 61